Prosecution Insights
Last updated: October 04, 2026

Matney Legal Group Pllc

Technology area: Biotechnology & Pharmaceuticals

7 pending office actions • 1 client • 7 examiners • 6 art units • 0 of 7 (0%) have an AI response strategy ready

Quality Metrics (n=167 apps, methodology: how we score firms)

94.6%
Allowance Rate
n=167
+0.69σ
Allowance Rate (norm)
n=167
3.1
OAs to Allowance
n=88
-0.48σ
OAs to Allow (norm)
n=88
1097 days
Time to Allowance
n=88
-4.3pp
Interview Lift
n=167
36.6%
RCE Rate
n=167
0.0%
Appeal Rate
n=167

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=12 (min 20)
63.0%
§102 Overcome
n=27
78.6%
§103 Overcome
n=56
70.7%
§112 Overcome
n=41

Specialization & Scale

A61F, A61L, C12N
Top CPC Subclasses
40%
Top-3 CPC Share
n=167
2
Practitioners
n=167
83.5
Apps / Practitioner
n=167

Portfolio Summary

7
Total Pending OAs
3
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (57%)
3
Medium (43%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (14%)
Double-patenting + other2 (29%)
Multi-statute (no §101)4 (57%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
14% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BERKE-SCHLESSEL, DAVID W 1 66.7% +31.8%
HERBERT, MADISON TAYLOR 1 59.1% +53.7%
JOHNSON, ALLISON MARIE 1 40.9% +53.3%
ALEMAN, SARAH WEBB 1 62.1% +23.7%
BATES, KEENAN ALEXANDER 1 45.5% +79.5%
STAVROU, CONSTANTINA E 1 43.7% +36.9%
VAN BUREN, LAUREN K 1 39.8% +58.1%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17731616 PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL JOHNSON, ALLISON MARIE 62d
17987257 CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES HERBERT, MADISON TAYLOR —
17695170 AORTOILIAC IMPLANT AND PROCESSING AND USES THEREOF ALEMAN, SARAH WEBB —
17506140 MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES BATES, KEENAN ALEXANDER —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17088860 ICE-FREE VITRIFICATION AND NANO WARMING OF LARGE TISSUE SAMPLES VAN BUREN, LAUREN K 72d overdue
17731616 PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL JOHNSON, ALLISON MARIE 62d
18757079 CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF BERKE-SCHLESSEL, DAVID W —
17987257 CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES HERBERT, MADISON TAYLOR —
17695170 AORTOILIAC IMPLANT AND PROCESSING AND USES THEREOF ALEMAN, SARAH WEBB —
17506140 MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES BATES, KEENAN ALEXANDER —
17603661 BIRTH TISSUE-DERIVED PRODUCTS AND PREPARATION AND USES THEREOF STAVROU, CONSTANTINA E —

Client Portfolio (1 client)

Client (Assignee)Pending OAs
LifeNet Health 7

Top Art Units

Art UnitApps
16382
16511
17581
37741
16311
16321

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18757079 CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF Lifenet Health BERKE-SCHLESSEL, DAVID W 1651 §112DP Non-Final OA — Pending Jun 27, 2024
17987257 CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES Lifenet Health HERBERT, MADISON TAYLOR 1758 §102§103 Final Rejection — Pending Nov 15, 2022
17731616 PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL Lifenet Health JOHNSON, ALLISON MARIE 1638 §102§103§112 Non-Final OA 62d Pending Apr 28, 2022
17695170 AORTOILIAC IMPLANT AND PROCESSING AND USES THEREOF Lifenet Health ALEMAN, SARAH WEBB 3774 §103§112 Final Rejection — Pending Mar 15, 2022
17506140 MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES Lifenet Health BATES, KEENAN ALEXANDER 1631 §103§112 Non-Final OA — Pending Oct 20, 2021
17603661 BIRTH TISSUE-DERIVED PRODUCTS AND PREPARATION AND USES THEREOF Lifenet Health STAVROU, CONSTANTINA E 1632 §102 Final Rejection — Pending Oct 14, 2021
17088860 ICE-FREE VITRIFICATION AND NANO WARMING OF LARGE TISSUE SAMPLES Lifenet Health VAN BUREN, LAUREN K 1638 §112DP Final Rejection 72d overdue Pending Nov 04, 2020

Managing Matney Legal Group Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month